Spero Therapeutics, Inc. ($SPRO)
Rajavelu Esther โ Chief Executive Officer, Chief Financial Officer and Chief Business Officer
Shares
25,240
Price
$2.51
Total Value
$63,352.40
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Rajavelu Esther |
|---|---|
| Title | Chief Executive Officer, Chief Financial Officer and Chief Business Officer |
| Transaction Date | May 4, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | May 7, 2026 |
| Shares Sold | 25,240 |
| Price per Share | $2.51 |
| Total Value | $63,352.40 |
| Shares Owned After | 986,851 |
| Derivative | No |
| Accession Number | 0001193125-26-209884 |
| Document | View SEC Filing |